Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Bosch

Showing results (871-880 of 1,009) with videos related to

Pageof 101
Sort By:
The Journal of Infectious Diseases|July 8, 2025
Antiviral Monocytes Increase Prior to Detectable HIV-1 Rebound ViremiaAnna Farrell-Sherman, Natalia de la Force, Cecilia A Prator, et al.
Journal of Virus Eradication|February 26, 2019
Stability of plasma indices of inflammation/coagulation and homeostasis after fatty and non-fatty meals in treated people with HIVDominic Dorazio, Douglas W Kitch, Netanya S Utay, et al.
Early Human Development|June 24, 2011
QEEG norms for the first year of lifeG A Otero, T Harmony, F B Pliego-Rivero, et al.
European Journal of Clinical Nutrition|February 8, 2019
Evidence of higher intramyocellular fat among normal and overweight Indians with prediabetesS Sucharita, R Pranathi, M Correa, et al.
Gastroenterology|October 19, 2001
Isosorbide mononitrate in the prevention of first variceal bleed in patients who cannot receive beta-blockersJ C García-Pagán, C Villanueva, M C Vila, et al.
The Journal of Infectious Diseases|September 13, 2014
Rifaximin has a marginal impact on microbial translocation, T-cell activation and inflammation in HIV-positive immune non-responders to antiretroviral therapy - ACTG A5286Allan R Tenorio, Ellen S Chan, Ronald J Bosch, et al.
Klinische Monatsblatter Fur Augenheilkunde|May 16, 2017
[New Therapeutic Approaches in Inflammatory Diseases of the Eye - Targeting Lymphangiogenesis and Cellular Immunity: Research Unit FOR 2240 Presents Itself]Claus Cursiefen, Felix Bock, Thomas Clahsen, et al.
The Journal of Infectious Diseases|March 7, 2023
Effect of Immune-Modulatory Interventions on Asymptomatic Cytomegalovirus Shedding During Suppressive Antiretroviral TherapyElizabeth Hastie, Carlee Moser, Xin Sun, et al.
Pharmacotherapy|March 28, 2025
Pharmacokinetic approaches to standardize antiviral exposure in cerebrospinal fluidSean N Avedissian, Ying Mu, Caitlyn McCarthy, et al.
Diabetes Care|February 13, 2008
Effects of ramipril and rosiglitazone on cardiovascular and renal outcomes in people with impaired glucose tolerance or impaired fasting glucose: results of the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) trial, G R Dagenais, H C Gerstein, et al.
Pageof 101

Showing results (871-880 of 1,009) with videos related to

Sort By:
Pageof 101
The Journal of Infectious Diseases|July 8, 2025
Antiviral Monocytes Increase Prior to Detectable HIV-1 Rebound ViremiaAnna Farrell-Sherman, Natalia de la Force, Cecilia A Prator, et al.
Journal of Virus Eradication|February 26, 2019
Stability of plasma indices of inflammation/coagulation and homeostasis after fatty and non-fatty meals in treated people with HIVDominic Dorazio, Douglas W Kitch, Netanya S Utay, et al.
Early Human Development|June 24, 2011
QEEG norms for the first year of lifeG A Otero, T Harmony, F B Pliego-Rivero, et al.
European Journal of Clinical Nutrition|February 8, 2019
Evidence of higher intramyocellular fat among normal and overweight Indians with prediabetesS Sucharita, R Pranathi, M Correa, et al.
Gastroenterology|October 19, 2001
Isosorbide mononitrate in the prevention of first variceal bleed in patients who cannot receive beta-blockersJ C García-Pagán, C Villanueva, M C Vila, et al.
The Journal of Infectious Diseases|September 13, 2014
Rifaximin has a marginal impact on microbial translocation, T-cell activation and inflammation in HIV-positive immune non-responders to antiretroviral therapy - ACTG A5286Allan R Tenorio, Ellen S Chan, Ronald J Bosch, et al.
Klinische Monatsblatter Fur Augenheilkunde|May 16, 2017
[New Therapeutic Approaches in Inflammatory Diseases of the Eye - Targeting Lymphangiogenesis and Cellular Immunity: Research Unit FOR 2240 Presents Itself]Claus Cursiefen, Felix Bock, Thomas Clahsen, et al.
The Journal of Infectious Diseases|March 7, 2023
Effect of Immune-Modulatory Interventions on Asymptomatic Cytomegalovirus Shedding During Suppressive Antiretroviral TherapyElizabeth Hastie, Carlee Moser, Xin Sun, et al.
Pharmacotherapy|March 28, 2025
Pharmacokinetic approaches to standardize antiviral exposure in cerebrospinal fluidSean N Avedissian, Ying Mu, Caitlyn McCarthy, et al.
Diabetes Care|February 13, 2008
Effects of ramipril and rosiglitazone on cardiovascular and renal outcomes in people with impaired glucose tolerance or impaired fasting glucose: results of the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) trial, G R Dagenais, H C Gerstein, et al.
Pageof 101